Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Evaluation of antiangiogenic and antitumor properties of anogeissus leiocarpus
Joint Event on 4th European Biopharma Congress & 6th International Conference and Exhibition on Pharmacology and Ethnopharmacology
Loiy Elsir Ahmed Hassan, Aman Shah Abdul Majid, Foud S Al-Suade, Saad S Dahham and Amin Malik Shah Abdul Majid
EMAN Research and Testing Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia
Omdurman Islamic University, Department of Pharmacology, Malaysia
Background: Anogeissus leiocarpus is a traditional medicinal plant with strong antioxidant and hypoglycemic properties. Hypothesis/Purpose: This study was aimed to investigate the antiangiogenic and cytotoxic effects of eight extracts from Anogeissus leiocarpa (leaves and bark). Study Design: Eventually, the most active extract was subjected to a series of in vitro and in vivo studies to elucidate the mechanism of action. Methods: In order to confirm the effect of the extract on motility of human endothelial cells, cell migration assay was conducted. In addition, VEGF suppressive effect of the extract was assessed in endothelial cells. Finally, the antitumor effect of the extract was evaluated using in vivo human tumor xenograft model. Results: Results of the present study indicated that, hexane extract of the stem bark of A. leiocarpus was found as the most active extract on inhibition of sprouting of microvessels (89.56%). Additionally, ethanol extract of the leaves exerted high antiangiogenic (inhibition 82.12%) in rat aortic ring assay. Hexane extract of the stem bark displayed significant inhibitory effect on endothelial cells proliferation (76.87 %) while ethanol extract of the leaves was save on HUVEC cell lines (inhibition 5.80%). The two extracts inhibited HUVEC migration by 87.57 and 65.23% respectively. The extracts demonstrated significant inhibition of VEGF levels (45.32 and 30.52 % respectively) in treated endothelial cells. Finally the extracts exhibited potent anti-tumorigneic effect in anthymic mice with ΓΆΒ?Β?T/ΓΆΒ?Β?C =8.43 and 12.54% at doses 400 and 200mg/kg, respectively. Conclusion: These results may provide novel guidelines towards improved strategies using Anogeissus leiocarpus extracts based on the suppression of angiogenesis to curb the growth of tumors. The plant can be used as promising candidate for antineoplastic drug development. Key words: Medicinal plants, Antitumor in vivo, antiangiogenic Anogeissus leiocarpus
Biography
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals